Circulating tumor cells can undergo epithelial‐mesenchymal transition (EMT) thereby reducing the expression of epithelial markers such as EpCAM and CK8/18/19 and increasing the expression of mesenchymal markers such as vimentin (Vim) and c‐MET [34, 35]. The gene discussed is EPCAM; the disease is neoplasm.